Cargando…

Metformin and Cancer in Type 2 Diabetes

Detalles Bibliográficos
Autor principal:	Park, Hyeong Kyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Diabetes Association 2013
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3638221/ https://www.ncbi.nlm.nih.gov/pubmed/23641351 http://dx.doi.org/10.4093/dmj.2013.37.2.113

Ejemplares similares

Severe Hypoglycemia and Cardiovascular Disease in Type 2 Diabetes
por: Park, Hyeong Kyu
Publicado: (2015)

Metformin and Colorectal Cancer Risk in Diabetic Patients
por: Ioannou, George N., et al.
Publicado: (2011)

Metformin Based Dual-Combination Therapies in Drug Naïve Type 2 Diabetic Patients
por: Kim, Dong-Lim
Publicado: (2013)

The Relationship between Metformin and Cancer in Patients with Type 2 Diabetes
por: Chung, Hyun Hee, et al.
Publicado: (2013)

Metformin improves diabetic kidney disease
por: Beladi Mousavi, Seyed Seifollah, et al.
Publicado: (2012)

Metformin, aging and cancer
por: Moiseeva, Olga, et al.
Publicado: (2013)

Metformin and Type 2 Diabetes Prevention
por: Aroda, Vanita R., et al.
Publicado: (2018)

The Anti-Diabetic Drug Metformin from the Neuropathy Perspective
por: Won, Jong Chul
Publicado: (2020)

Metformin and Biliary Tract Cancer in Patients With Type 2 Diabetes
por: Tseng, Chin-Hsiao
Publicado: (2020)

Reduction of Depression in Diabetes: A New Pleiotropic Action of Metformin?
por: Papachristou, Stella, et al.
Publicado: (2021)

Metformin in breast cancer - an evolving mystery
por: Camacho, Laura, et al.
Publicado: (2015)

Metformin and Exercise in Cancer: Better Together
por: Stambolic, Vuk, et al.
Publicado: (2019)

Metformin and breast cancer: an opportunity for pharmacogenetics
por: Cuyàs, Elisabet, et al.
Publicado: (2022)

Comparison of Vildagliptin-Metformin and Glimepiride-Metformin Treatments in Type 2 Diabetic Patients
por: Jeon, Hyun Jeong, et al.
Publicado: (2011)

The Efficacy of Vildagliptin in Korean Patients with Type 2 Diabetes
por: Moon, Jun Sung, et al.
Publicado: (2013)

Metformin induces protein acetylation in cancer cells
por: Vancura, Ales, et al.
Publicado: (2017)

The Use of Metformin and the Incidence of Lung Cancer in Patients With Type 2 Diabetes
por: Smiechowski, Brielan B., et al.
Publicado: (2013)

Metformin and Cancer Occurrence in Insulin-Treated Type 2 Diabetic Patients
por: Monami, Matteo, et al.
Publicado: (2011)

The effect of metformin on breast cancer outcomes in patients with type 2 diabetes
por: Oppong, Bridget A, et al.
Publicado: (2014)

Metformin and lung cancer risk in patients with type 2 diabetes mellitus
por: Tseng, Chin-Hsiao
Publicado: (2017)

The Effect of Metformin on the Clinicopathological Features of Breast Cancer With Type 2 Diabetes
por: Min, Weili, et al.
Publicado: (2020)

Are There Differences in Gut Microbiome in Patients with Type 2 Diabetes Treated by Metformin or Metformin and Insulin?
por: Dzięgielewska-Gęsiak, Sylwia, et al.
Publicado: (2022)

Effect of the combination of mitiglinide and metformin on glycemic control in patients with type 2 diabetes mellitus
por: Cho, Young Min, et al.
Publicado: (2010)

Introduction: Real-World Evidence in Type 2 Diabetes
por: Hassanein, Mohamed, et al.
Publicado: (2020)

Effects of metformin on endothelial function in type 2 diabetes
por: WU, SONGLIN, et al.
Publicado: (2014)

Metformin and the Risk of Dementia in Type 2 Diabetes Patients
por: Chin-Hsiao, Tseng
Publicado: (2019)

Role of Metformin on Osteoblast Differentiation in Type 2 Diabetes
por: Jiating, Lin, et al.
Publicado: (2019)

Metformin and the Development of Asthma in Patients with Type 2 Diabetes
por: Yen, Fu-Shun, et al.
Publicado: (2022)

Long-term effects of metformin use in gestational diabetes mellitus on offspring health
por: Roy, Ayan, et al.
Publicado: (2021)

Comparison of Vildagliptin and Pioglitazone in Korean Patients with Type 2 Diabetes Inadequately Controlled with Metformin
por: Kim, Jong Ho, et al.
Publicado: (2016)

A Pharmacometabolomic Approach to Predict Response to Metformin in Early-Phase Type 2 Diabetes Mellitus Patients
por: Park, Jeong-Eun, et al.
Publicado: (2018)

Metformin and the promise of geroprotection
por: Kalra, Sanjay, et al.
Publicado: (2012)

Metformin turns off the metabolic switch of pancreatic cancer
por: Deschênes-Simard, Xavier, et al.
Publicado: (2019)

Metformin reduces the risk of cancer in patients with type 2 diabetes: An analysis based on the Korean National Diabetes Program Cohort
por: Kim, Hae Jin, et al.
Publicado: (2018)

Metformin Therapy and Risk of Cancer in Patients with Type 2 Diabetes: Systematic Review
por: Franciosi, Monica, et al.
Publicado: (2013)

Metformin Associated With Lower Cancer Mortality in Type 2 Diabetes: ZODIAC-16
por: Landman, Gijs W.D., et al.
Publicado: (2010)

Incidence of Bladder Cancer in Patients With Type 2 Diabetes Treated With Metformin or Sulfonylureas
por: Mamtani, Ronac, et al.
Publicado: (2014)

Metformin Reduces Thyroid Cancer Risk in Taiwanese Patients with Type 2 Diabetes
por: Tseng, Chin-Hsiao
Publicado: (2014)

Metformin may reduce oral cancer risk in patients with type 2 diabetes
por: Tseng, Chin-Hsiao
Publicado: (2015)

Influence of metformin intake on the risk of bladder cancer in type 2 diabetes patients
por: Goossens, Maria (Mieke), et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_k6spep4g5qabd6kdl3gh1p37it